The Preimplantation Genetic Testing Market - Introduction
Preimplantation genetic testing is the process which is used prior to implantation to help identify genetic defects within embryos. This process helps to prevent certain genetic disorders that can transfer from parents to child. It involves screening single cells from embryos and performed during the process of in-vitro fertilization (IVF) prior to embryo transfer. Two main procedures are done for preimplantation genetic testing: preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS). The main application of PGD is to identify the presence of chromosomal translocations and single-gene disorders so that these embryos are not transferred and a healthy, disease free baby’s birth can take place. This process is also done to determine the sex of the embryo prior to the transfer into the uterus. Different techniques are used in preimplantation genetic testing such as Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), and Fluorescence in Situ Hybridization (FISH) for detection of disorders.
Preimplantation genetic screening (PGS) is applied technology from PGD and generally done for those people with recurrent pregnancy loss or infertility. Embryos are screened to determine the cause of miscarriage and implantation failure. Through this screening, abnormal embryos are identified so they are not transferred to the IVF cycle, to achieve successful pregnancy. PGS is done to screen an embryo for normal chromosome number or to identify loss or gain of chromosomal material.
Stuck in a Neck-to-Neck Competition with Other Brands? Request a Custom Report on “Preimplantation Genetic Testing Market” here
Preimplantation Genetic Testing Market – Competitive Landscape
The global preimplantation genetic testing market is fragmented due to presence of major players. Key players operating in the global preimplantation genetic testing market include Agilent Technologies, Inc., Illumina, Inc., Abbott Laboratories, CooperSurgical, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc., Natera, Inc., Quest Diagnostics Incorporated, Genea Limited, and Vitrolife.
New product launch, partnerships, collaborations, and mergers & acquisitions are some of the key strategies adopted by these major players in developed as well as emerging economies. For instance, in January 2017, Agilent Technologies, Inc. and the Centre for Human Genetics, University of Leuven, and University Hospitals Leuven collaborated to investigate new solutions of preimplantation genetic testing.
Agilent Technologies, Inc.
Agilent Technologies, Inc. is headquartered in Santa Clara, CA, U.S. and operates in life sciences, diagnostics, and applied chemicals markets. The company was founded in 1999 and offers instruments, services, consumables, applications, and expertise to address the full range of scientific and laboratory management needs. Agilent Technologies, Inc. provides OnePGT Solution for research purposes which uses NGS technology.
Founded in 1998, Illumina, Inc.is based in San Diego, California, U.S. The company develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It has a global presence with over 7,300 employees globally. Illumina, Inc. offers various karyomapping products and solutions for PGD such as Infinium HumanKaryomap-12 DNA Analysis Kit and NextSeq 550 System.
The company has adopted a distribution partnership, collaboration, and alliances strategy for its PGD products. For instance, in October 2018, Illumina, Inc. and Vitrolife signed a distribution agreement. This agreement provided exclusive development, distribution, and commercialization rights to Vitrolife for Illumina, Inc’s. Preimplantation genetic testing business for IVF in the Americas and EMEA.
Established in 1888, Abbott Laboratories is headquartered in Chicago, Illinois, U.S. Abbott Laboratories is a major healthcare company which offers healthcare products and solutions such as diagnostics, medical devices, nutritionals, and branded generic medicines. The company serves more than 160 countries. Its PGD products and solutions comes under the genetics and genomics product division.
Founded in 1990, CooperSurgical, Inc. is based in Trumbull, Connecticut, U.S. The company has a diversified product portfolio of more than 600 products. It operates through two business segments: CooperSurgical medical devices and CooperSurgical Fertility & genomic solutions. The company offers PGT-A, PGT-M, and PGT-SR, which are major test solutions for PGD and PGS.
Preimplantation Genetic Testing Market- Dynamics
Rise in number of cases of child birth with genetic disorders and declining fertility rate globally to drive the global preimplantation genetic testing market
Increasing incidence of child birth with genetic disorders such as cystic fibrosis, Huntington’s disease, Down syndrome, and Turner syndrome due to chromosomal abnormalities, single gene defects, and other reasons is being seen. Rise in conditions of genetic disorders & abnormalities is attributed to growth of global preimplantation genetic testing market. For instance, as per CDC, around 6,000 babies are born with Down syndrome in the U.S. every year. According to the same report, between1979 to 2003, and the number of babies born with Down syndrome increased by about 30% in the U.S. Moreover, fertility rate among the current population is declining in recent years due to lifestyle changes which is propelling the need for PGS and hence the preimplantation genetic testing market is slated to grow globally.
Need an Overview of the Report on Preimplantation Genetic Testing Market? Ask for the Brochure here
Higher risk of chromosomal abnormalities associated with advancing maternal age and more IVF procedures coupled with rise in number of fertility clinics, major growth drivers of the market
The risk of chromosomal abnormality increases with maternal age. A baby born to an older woman has higher risk of being born with some type of chromosomal abnormality & defect. According to an article published by Stanford Children's Health, U.S., the chance of having a child affected by Down syndrome rises from around 1 in 1,250 for a woman who conceives at the age of 25 years, to about 1 in 100 for a woman who conceives at the age of 40 years. Also, rise in number of fertility clinics and IVF procedures worldwide is propelling the growth of the global preimplantation genetic testing market.
Higher procedural cost and certain regulatory norms restraining the market growth
Factors such as higher cost associated with PGD & PGS and certain strict regulatory norms are likely to hamper the growth of the global preimplantation genetic testing market. Preimplantation genetic testing is a complex procedure that entails a lot of laboratory work; hence, the cost can be significant and high for the entire procedure. Also, non-medical use of PGD and PGS raises the government regulatory norms in certain countries. These strict rules are likely to hamper the growth of the global preimplantation genetic testing market.
North America preimplantation genetic testing Market – Major Market
North America dominated the global preimplantation genetic testing market in 2018. It is projected to maintain its position during the forecast period. Higher infertility rate, more number of IVF cycles, presence of major players in the region, and adoption of highly advanced technologies for genomics are some of the major factors responsible for the dominance of this region in the global market. For instance, according to CDC data, between 2011 to 2015, 6.7% of married women aged 15-44 years were facing infertility problems in the U.S.
Preimplantation Genetic Testing Market - Segmentation
The global market can be segmented on the basis of:
- Procedure Type
- Product & services
Preimplantation Genetic Testing Market Segmentation – By Procedure Type
Based on procedure type, the market can be segmented into:
- Preimplantation Genetic Diagnosis
- Preimplantation Genetic Screening
Preimplantation Genetic Testing Market Segmentation – By Product & Services
In terms of product & services, the market can be divided into:
- Reagents & Consumables
- Softwares & Services
Preimplantation Genetic Testing Market Segmentation – By Technology
On the basis of technology, the market can be classified into:
- Polymerase Chain Reaction(PCR)
- Next-Generation Sequencing(NGS)
- Fluorescence in Situ Hybridization(FISH)
Preimplantation Genetic Testing Market Segmentation – By Application
Depending on application, the market can be segmented into:
- Single Gene Disorders
- Structural Chromosomal Abnormalities
- Gender Identification
- HLA Typing
Structural Chromosomal Abnormalities segment is further sub segmented into-
Preimplantation Genetic Testing Market Segmentation – By End-user
Based on end-user, the market can be divided into:
- Hospitals, Diagnostic Labs & Service Providers
- Maternity & Fertility Centers
- Research Laboratories & Academic Institutes
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.